Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; 23 of the 43 sources its claims cite were checked for support.

Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus

Open access
Wang, Xia, Zhang, Mei, Liu, Zhi, Li, Chuan, Li, Yujue, Huang, Hengjian, He, He, Yu, Xijie · 2025 · Frontiers in Endocrinology

Abstract

Objectives: Variability in biomarkers is crucial for clinical decision-making in individuals with type 2 diabetes mellitus (T2DM). The biological variation (BV) of biomarkers associated with thyroid function, iron metabolism, and bone metabolism may show population-specific differences. This study aims to evaluate the biological variation of sixteen biomarkers in T2DM patients and compare these with variations observed in a healthy population. Methods: Twenty-four T2DM patients, aged 43 to 67 and in stable condition, were enrolled. Blood samples were collected biweekly for three months. Analysis of variance models were used to assess the BV, including within-subject BV (CV I), between-subject BV (CV G), analytical variation, reference change value (RCV), index of individuality (II), the number of samples required for steady-state set points (NHSP), and analytical performance specifications for all biomarkers. Results: Females exhibited lower CV I estimates for thyroid-stimulating hormone, parathyroid hormone, and phosphate compared to males. No significant differences in CV I estimates were observed between T2DM patients and healthy individuals across the study. However, the CV G estimates for cortisol and iron were significantly lower in T2DM patients compared to the healthy individuals. Conclusions: BV data is critical for the precise interpretation of serial biomarker level changes in T2DM patients. It is deemed reasonable to use RCVs for four bone metabolism markers and five thyroid biomarkers, derived from a healthy population, as a reference for monitoring T2DM patients.

Overview

CoChat Summary

TL;DR

This study estimated biological variation (BV) for 16 thyroid, iron metabolism, and bone metabolism biomarkers in 24 patients with stable type 2 diabetes mellitus (T2DM) sampled biweekly for three months. Overall within-subject BV was similar to healthy populations, but between-subject BV for cortisol and iron was lower in T2DM, and the authors concluded that healthy-population reference change values (RCVs) are reasonable for four bone and five thyroid biomarkers in stable T2DM patients.

Key findings

  • In 24 T2DM patients (11 men, 13 women; 136 results), female CVI estimates were lower than male estimates for TSH (15.2% vs 21.9%), PTH (15.2% vs 21.9%), and PHOS (5.6% vs 10.1%) based on non-overlapping 95% CIs.
  • No significant differences in CVI estimates were observed between T2DM patients and healthy individuals across the study, but CVG estimates for cortisol and iron were significantly lower in T2DM than in the EFLM BV database: cortisol 18.8% vs 33.6%, and iron 9.7% vs 26.7%.
  • Index of individuality (II) values were <0.6 for five thyroid hormones, INS, C-P, 25(OH)D, and TIBC, whereas II values were >1.4 for iron (1.98), TSAT (1.53), and Ca (1.43). Example RCVs were TSH −39.7%; +65.8% and iron −41.2%; +70.3%.
  • The authors conclude it is reasonable to use RCVs for four bone metabolism markers and five thyroid biomarkers derived from a healthy population as a reference for monitoring stable T2DM patients.

Methods

  • Prospective BV study enrolling 24 T2DM patients aged 43–69 years (inclusion criteria 18–70 years) on stable diabetes medication for at least 3 months, excluding insulin, vitamin D supplements, or thyroid-affecting medications; fasting venous blood was collected biweekly six times over three months, with 20 participants completing all six collections and four completing four collections (mean 5.7 samples per participant).
  • Sixteen serum/plasma biomarkers were measured: thyroid markers (TSH, FT3, FT4, T3, T4), cortisol, insulin, C-peptide, intact PTH, 25(OH)D, calcium, phosphate, iron, UIBC, TSAT, and TIBC; assays used Roche Cobas e601 and Cobas 8000, with all samples measured in duplicate in a single run.
  • Analysis used ANOVA or CV-ANOVA for CVA and CVI, nested ANOVA for CVG after outlier testing, Shapiro-Wilk testing with log-transformation for non-normal data, linear regression for steady state, Miller’s formula for 95% CIs, and non-overlapping 95% CIs to define significant differences; RCV, II, NHSP, and analytical performance specifications were calculated.

Limitations

  • The paper states that the study mainly focused on patients over 50 years old, with only three patients between 40 and 50 years of age, highlighting a gap in BV assessment for younger patients; it also notes that hormonal analytes are influenced by rhythms and seasons and that more precise BV analysis is needed.
  • The paper states that CVA was derived from repeated samples and that laboratories should estimate RCVs based on their specific conditions.
  • Evident from the text: the sample was small (24 enrolled, only 20 completed all six collections), there was no concurrent healthy control group, and comparisons with healthy populations relied on the EFLM BV database or previously published studies; the abstract reports ages 43–67 while the results report 43–69.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fendo.2025.1506664

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

13 Valid · 3 Not valid · 15 Not checked · 21 Own results and interpretations

25 more claims · 3 with their cited sources checked

Create a free account to see all 52 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 43 references

Metadata

Authors
Wang, X., Zhang, M., Liu, Z., Li, C., Li, Y., Huang, H., He, H., & Yu, X.
Affiliations
  • Sichuan University (CN)
  • University of Electronic Science and Technology of China (CN)
Corresponding author
  • He, He
  • Yu, Xijie
Venue
Frontiers in Endocrinology
Published
2025-05-20
Volume
16
Pages
1506664-1506664
ISSN
1664-2392 (ISSN-L)
OpenAlex
W4410523281
Cited by
0
References
43
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Sichuan University
  • West China Hospital, Sichuan University
Topics
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
biological variation, type 2 diabetes, thyroid function biomarkers, iron metabolism, bone turnover markers, reference change value, thyroid-stimulating hormone, parathyroid hormone, phosphate, cortisol, sex differences, within-person variability, between-subject variability
MeSH terms
Adult, Aged, Bone and Bones, Diabetes Mellitus, Type 2, Female, Humans, Iron, Male, Middle Aged, Thyroid Gland, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.3389/fendo.2025.1506664
The paper
Wang, X., Zhang, M., Liu, Z., Li, C., Li, Y., Huang, H., He, H., & Yu, X. (2025). Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1506664

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.